The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer.

Schaefer ML, Tsai S, Blair AB

Open source

DOI
10.1245/s10434-026-20366-0
Published
2026 Sep 12
Container
Annals of surgical oncology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1245/s10434-026-20366-0,
  title = {The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer.},
  author = {Schaefer ML and Tsai S and Blair AB},
  year = {2026},
  journal = {Annals of surgical oncology},
  doi = {10.1245/s10434-026-20366-0},
  url = {https://doi.org/10.1245/s10434-026-20366-0}
}

RIS

TY  - JOUR
TI  - The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer.
AU  - Schaefer ML
AU  - Tsai S
AU  - Blair AB
PY  - 2026
JO  - Annals of surgical oncology
DO  - 10.1245/s10434-026-20366-0
UR  - https://doi.org/10.1245/s10434-026-20366-0
ER  - 

APA

ML, S., S, T., & AB, B. (2026). The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer.. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-20366-0

Source records